Drug-Induced Hyperthermia Review
Authors:
- Ladan PanahiLPLadan Panahi
- George UdeaniGUGeorge Udeani
- Andrew S. TenpasATAndrew S. Tenpas
- Rene Verduzco Jr.RJRene Verduzco Jr.
- Pooja H. PatelPPPooja H. Patel
- Daniela Z. BazanDBDaniela Z. Bazan
- Andrea MoraAMAndrea Mora
- Nephy SamuelNSNephy Samuel
- Anne-Cecile MingleAMAnne-Cecile Mingle
- Lisa R. LeonLLLisa R. Leon
- Joseph VaronJVJoseph Varon
Open Access
- 26 July 2022
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27278
Abstract
Humans maintain core body temperature via a complicated system of physiologic mechanisms that counteract heat/cold fluctuations from metabolism, exertion, and the environment. Overextension of these mechanisms or disruption of body temperature homeostasis leads to bodily dysfunction, culminating in a syndrome analogous to exertional heat stroke (EHS). The inability of this thermoregulatory process to maintain the body temperature is caused by either thermal stress or certain drugs. EHS is a syndrome characterized by hyperthermia and the activation of systemic inflammation. Several drug-induced hyperthermic syndromes may resemble EHS and share common mechanisms. The purpose of this article is to review the current literature and compare exertional heat stroke (EHS) to three of the most widely studied drug-induced hyperthermic syndromes: malignant hyperthermia (MH), neuroleptic malignant syndrome (NMS), and serotonin syndrome (SS). Drugs and drug classes that have been implicated in these conditions include amphetamines, diuretics, cocaine, antipsychotics, metoclopramide, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and many more. Observations suggest that severe or fulminant cases of drug-induced hyperthermia may evolve into an inflammatory syndrome best described as heat stroke. Their underlying mechanisms, symptoms, and treatment approaches will be reviewed to assist in accurate diagnosis, which will impact the management of potentially life-threatening complications.Keywords
This publication has 145 references indexed in Scilit:
- Eicosapentaenoic Acid Enhances Heat Stress-Impaired Intestinal Epithelial Barrier Function in Caco-2 CellsPLOS ONE, 2013
- Skin histology and its role in heat dissipation in three pinniped speciesActa Veterinaria Scandinavica, 2012
- Malignant hyperthermia: pharmacology of triggeringBritish Journal of Anaesthesia, 2011
- Low level bacterial endotoxin activates two distinct signaling pathways in human peripheral blood mononuclear cellsJournal of Inflammation, 2011
- Hsp-72, a candidate prognostic indicator of heatstrokeCell Stress and Chaperones, 2010
- Neuroleptic malignant syndrome: a neuroimmunologic hypothesisCanadian Medical Association Journal, 2010
- HSP72 Protects Cells from ER Stress-induced Apoptosis via Enhancement of IRE1α-XBP1 Signaling through a Physical InteractionPLOS Biology, 2010
- Cardiovascular function in the heat‐stressed humanActa Physiologica, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Bench-to-bedside review: Mechanisms and management of hyperthermia due to toxicityCritical Care, 2007